Cited by 464Diabetes Treatment and ManagementDiabetes Management and ResearchDiabetes and associated disorders

Consensus report: definition and interpretation of remission in type 2 diabetes

Open access
Riddle, Matthew C., Cefalu, William T., Evans, Philip H., Gerstein, Hertzel C., Nauck, Michael A., Oh, William K., Rothberg, Amy E., le Roux, Carel W. +4 more·2021·Diabetes Care

Abstract

Improvement of glucose levels into the normal range can occur in some people living with diabetes, either spontaneously or after medical interventions, and in some cases can persist after withdrawal of glucose-lowering pharmacotherapy. Such sustained improvement may now be occurring more often due to newer forms of treatment. However, terminology for describing this process and objective measures for defining it are not well established, and the long-term risks versus benefits of its attainment are not well understood. To update prior discussions of this issue, an international expert group was convened by the American Diabetes Association to propose nomenclature and principles for data collection and analysis, with the goal of establishing a base of information to support future clinical guidance. This group proposed “remission” as the most appropriate descriptive term, and HbA1c <6.5% (48 mmol/mol) measured at least 3 months after cessation of glucose-lowering pharmacotherapy as the usual diagnostic criterion. The group also made suggestions for active observation of individuals experiencing a remission and discussed further questions and unmet needs regarding predictors and outcomes of remission.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dci21-0034

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 39 · Cited by 464

Authors
Riddle, M. C., Cefalu, W. T., Evans, P. H., Gerstein, H. C., Nauck, M. A., Oh, W. K., Rothberg, A. E., le Roux, C. W., Rubino, F., Schauer, P., Taylor, R., & Twenefour, D.
Affiliations
  • Oregon Health & Science University (US)
  • National Institutes of Health (US)
  • University of Exeter (GB)
  • Population Health Research Institute (CA)
  • St. Josef-Hospital (DE)
  • Tisch Cancer Institute (US)
  • University of Michigan (US)
  • Diabetes Complications Research Centre, University College Dublin, Dublin, Ireland
  • King's College London (GB)
  • Pennington Biomedical Research Center (US)
  • Newcastle University (GB)
  • Diabetes UK (GB)
Corresponding author
Riddle, Matthew C.
Venue
Diabetes Care
Published
2021-08-30
Volume
44
Issue
10
Pages
2438-2444
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W3196921676
Cited by
464
References
39
Citations by year
2026: 92 · 2025: 103 · 2024: 124 · 2023: 72 · 2022: 63 · 2021: 9
FWCI
10.29
Type
journal article
Language
en
Open access
Locations
  • Diabetes Care (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Eli Lilly and Company
  • AstraZeneca
  • GlaxoSmithKline
  • Sanofi
  • McMaster University
  • Kowa Company
  • Pacira BioSciences
  • Cystic Fibrosis Trust (SRC 019)
  • Diabetes UK
  • Science Foundation Ireland
  • Irish Research Council
  • Novo Nordisk
  • Vetenskapsrådet
  • Astellas Pharma
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30DK020572)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
Keywords
type 2 diabetes, diabetes remission, HbA1c, remission definition, nomenclature, remission monitoring, predictors of remission, risk-benefit assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review